lundi 25 janvier 2016

Onco Actu du 25 janvier 2016

3.1 Tabac

E-cigarettes tied to reduced odds of quitting smoking [Reuters]

4.2 Dép., diag. & prono. - Génome

Precision cancer treatment held back by low-quality biopsies [STAT]

4.5 Dép., diag. & prono. - Colorectal

1 in 7 colorectal cancer patients diagnosed before recommended screening age [University of Michigan Health System]

Colonoscopy at 40? Study finds a possible benefit [STAT]

Screening gets top marks for picking up bowel cancer early [Cancer Research UK]

5. Traitements

NHS fast-tracks drug docetaxel for advanced prostate cancer patients [The Guardian]

5.2 Pharma

OncoGenex Announces Update on Phase 2 Spruce Trial in Previously Untreated Metastatic Non-Small Cell Lung Cancer [oncoGenex]

5.2.3 Pharma - économie

Heat Biologics Seeks More Cash for Bladder Cancer Immunotherapy Push [Xconomy]

5.3 Traitements - FDA, EMA,...

Pfizer's Ibrance on track for UK early access scheme [Pharma Times]

5.3.4 Traitements - AMM (FDA, EMA)

FDA approves new Kyprolis combo for multiple myeloma [Pharmafile]

FDA approves new uses for BMS’ Opdivo/Yervoy cancer combo [Pharmafile]

Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Status [BMS]

5.4 Traitements - Economie

Patient groups funded by drugmakers are largely mum on high drug prices [USA Today]

NY Governor Andrew Cuomo seeks to cap some drug prices [STAT]

NICE draft guidance recommends nivolumab for advanced skin cancer [NICE]

5.5 ASCO

NewLink Genetics Presents Phase 1b Data of Indoximod in Combination With Gemcitabine/Nab-Paclitaxel for Patients With Metastatic Pancreatic Cancer That Show Encouraging Durable Responses With Delayed Pattern [NewLink Genetics]

Adjuvant Therapy of Pancreas Cancer: Have We Raised The Bar? [Gastrointestinal Cancers Symposium]

Optimizing Immunotherapy in Colorectal Cancer [Gastrointestinal Cancers Symposium]

Data Presented at ASCO GI Highlight the Feasibility of Second-Line Treatment in Patients with Metastatic Pancreatic Cancer Who Have Received First-Line Abraxane Plus Gemcitabine [Celgene]

6. Lutte contre les cancers

Women with high risk of cancer effectively told 'come back when you have tumours' [The Telegraph]

6.10 Politiques

Vice President Biden's cancer research initiative [National Cancer Institute]

6.9 Controverses

Attack of the Research Parasites [In the Pipeline]